Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Live Streamed
On Demand
Back
Favorite
Facebook
Tweet
Print
Erica Chilson, PharmD
Senior Director, US Medical Affairs
Pfizer
Poster(s):
(P-8) Assessment of 13-valent pneumococcal conjugate vaccine effectiveness among people living with HIV in the United States
Thursday, October 17, 2024
12:15 PM – 1:30 PM
US PT
(P-603) Potential Public Health Impact of Respiratory Syncytial Virus (RSV) Vaccines for Prevention of RSV Among Older Adults in the United States
Thursday, October 17, 2024
12:15 PM – 1:30 PM
US PT
(P-604)
Preliminary real-world Abrysvo vaccine effectiveness (VE) against Respiratory Syncytial Virus (RSV)-related lower respiratory tract disease (LRTD) hospitalizations and emergency department (ED) visits—Kaiser Permanente of Southern California (KPSC), November 2023-April 2024
Thursday, October 17, 2024
12:15 PM – 1:30 PM
US PT
(P-682) The Risk of Cardiorespiratory Events for up to 180 days Following Respiratory Syncytial Virus (RSV) Infection Hospitalization: A Self-controlled Case Series Analysis
Thursday, October 17, 2024
12:15 PM – 1:30 PM
US PT